HAYWARD, Calif.--(BUSINESS WIRE)--Moximed, Inc. announced today that the KineSpring® System, an implantable medical spring for knee osteoarthritis that works by unloading the weight on the diseased joint, has been successfully implanted in the first patients enrolled in the UK arm of its multi-centre GOAL study. This non-randomized pivotal trial is comparing the safety and effectiveness of the KineSpring System with high tibial osteotomy (HTO), a procedure used to treat the pain and discomfort associated with medial compartment knee osteoarthritis, in a minimum of 225 patients across Europe. The UK principal investigator for the study is Mr. Michael McNicholas, Consultant Trauma and Orthopaedic surgeon, Aintree University Hospital, Liverpool.
Help employers find you! Check out all the jobs and post your resume.
